Dengue: a continuing global threat
Open accessThe DOI matches its Crossref record; 129 of the 130 references it cites were found in a registry or an index.
Abstract
Dengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are ∼50 million dengue infections and ∼500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly in Southeast Asia, the Pacific and the Americas. Illness is produced by any of the four dengue virus serotypes. A global strategy aimed at increasing the capacity for surveillance and outbreak response, changing behaviours and reducing the disease burden using integrated vector management in conjunction with early and accurate diagnosis has been advocated. Antiviral drugs and vaccines that are currently under development could also make an important contribution to dengue control in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Until recent advances in vaccine development [16–17], and the approval and potential availability of the first product in 2016 [18], dengue has been unique among the major vector-borne diseases, in that prevention from infection could only be attempted by reducing or eliminating bites by infected vector mosquitoes [19, 20].”
From Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis (2016) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although a vaccine could be available as early as 2016, vector control remains the primary approach used to prevent dengue, the most common and widespread arbovirus of humans worldwide.”
From Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis (2016) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dengue and Dengue Hemorrhagic Fever
Gubler, D. J. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.480 · Cited by 4,310
Self-citationLanciotti, R. S., Calisher, C. H., Gubler, D. J., Chang, G. J., & Vorndam, A. V. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.3.545-551.1992 · Cited by 1,818 · cited 1×
“The most E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s commonly used NAATs are based on a single RT-PCR assay 95,96 , a nested RT-PCR assay 96 or a one-step multiplex RT-PCR assay 97 .”
MethodSelf-citationDengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B. L., Nimmannitya, S., Suntayakorn, S., Endy, T. P., Raengsakulrach, B., Rothman, A. L., Ennis, F. A., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315215 · Cited by 1,632 · cited 1×
“One advantage of this assay is the ability to determine viral titre early in dengue illness, which is believed to be an important predictor of disease severity 102 .”
BackgroundGuzmán, M. G., & Kouri, G. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00171-2 · Cited by 1,163
Spectrum of Disease and Relation to Place of Exposure among Ill Returned Travelers
Freedman, D. O., Weld, L. H., Kozarsky, P. E., Fisk, T., Robins, R., von Sonnenburg, F., Keystone, J. S., Pandey, P., & Cetron, M. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051331 · Cited by 1,081
Dengue and dengue haemorrhagic fever
Rigau-Pérez, J. G., Clark, G. G., Gubler, D. J., Reiter, P., Sanders, E. J., & Vance Vorndam, A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)12483-7 · Cited by 1,051
Self-citationCross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Dejnirattisai, W., Jumnainsong, A., Onsirisakul, N., Fitton, P., Vasanawathana, S., Limpitikul, W., Puttikhunt, C., Edwards, C., Duangchinda, T., Supasa, S., et al. (2010) · Science · doi:10.1126/science.1185181 · Cited by 943 · cited 1×
“The available data suggest that neutralizing antibodies are the major contributors to protective immunity 124,125 , however the role of the cellular immune response requires further study 123 .”
BackgroundCalisher, C. H., Karabatsos, N., Dalrymple, J. M., Shope, R. E., Porterfield, J. S., Westaway, E. G., & Brandt, W. E. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-1-37 · Cited by 893 · cited 1×
“These tests are mainly for research and vaccine studies 90–94 .”
BackgroundOriginal antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
Mongkolsapaya, J., Dejnirattisai, W., Xu, X.-N., Vasanawathana, S., Tangthawornchaikul, N., Chairunsri, A., Sawasdivorn, S., Duangchinda, T., Dong, T., Rowland-Jones, S., et al. (2003) · Nature Medicine · doi:10.1038/nm887 · Cited by 821 · cited 1×
“…CD4 + and CD8 + cells that have a diminished capacity to kill but nonetheless release inflammatory cytokines that contribute to disease severity 51 ; that severe disease is caused by DENVs of increased virulence 52 ; and the suggestion that cross-reactivity between NS1 and human platelets and…”
BackgroundDengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
Halstead, S., & O'Rourke, E. (1977) · The Journal of Experimental Medicine · doi:10.1084/jem.146.1.201 · Cited by 804 · cited 5×
“Both in vitro and in vivo , macrophages and monocytes participate in antibody-dependent enhancement (ADE) 18–20 .”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 3
- Vorndam, V. & Kuno, G. In Dengue and Dengue Hemorrhagic Fever (eds Gubler, D. J. & Kuno, G.) 313–333 (CAB International, New York, USA, 1997).
- Gubler, D. J. Serologic diagnosis of dengue/dengue haemorrhagic fever. Dengue Bull. 20, 20–23 (1996).
- Singh, K. R. P. & Paul, S. D. Multiplication of arboviruses in cell lines from Aedes albopictus and Aedes aegypti. Curr. Sci. 37, 65–67 (1968).
Cited by
Items 501–600 of 1,001
Prattay, K. M. R., Sarkar, M. R., Shafiullah, A. Z., Islam, M. S., Raihan, S. Z., & Sharmin, N. (2022) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0010297 · Cited by 39
“Dengue is a systemic, febrile disease caused by a mosquito-borne virus known as Dengue virus (DENV) and is one of the major public health problems in tropical and subtropical countries [1,2].”
BackgroundVervaeke, P., Alen, M. M. F., Noppen, S., Schols, D., Oreste, P., & Liekens, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074035 · Cited by 39
“izations and 25,000 deaths [1,2].”
Belinato, T. A., Martins, A. J., Lima, J. B. P., & Valle, D. (2013) · Parasites & Vectors · doi:10.1186/1756-3305-6-83 · Cited by 40
“; licensee BioMed Centra Commons Attribution License (http://creativec reproduction in any medium, provided the or because they are involved in transmission of diseases, such as dengue, yellow fever and lymphatic filariasis [2-4].”
BackgroundRegulation of flavivirus RNA synthesis and capping
Saeedi, B. J., & Geiss, B. J. (2013) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1191 · Cited by 57
da Costa, V. G., Marques-Silva, A. C., Floriano, V. G., & Moreli, M. L. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.07.008 · Cited by 40
Prūsis, P., Junaid, M., Petrovska, R., Yahorava, S., Yahorau, A., Katzenmeier, G., Lapins, M., & Wikberg, J. E. S. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.03.139 · Cited by 38
“There are four highly homologous but antigenically distinct serotypes of the virus (DEN-1–4), and immunity against one serotype does not protect against infection by another serotype; instead it may enhance disease severity upon infection with another serotype [1].”
BackgroundFerraz, F. O., Bomfim, M. R. Q., Tótola, A. H., Ávila, T. V., Cisalpino, D., Pessanha, J. E. M., de Souza, D. D. G., Teixeira, A. L., Nogueira, M. L., Bruña–Romero, O., et al. (2013) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.06.015 · Cited by 38
Design of SERS nanotags for multiplexed lateral flow immunoassays
Sánchez-Purrà, M., Roig-Solvas, B., Versiani, A. F., Rodriguez-Quijada, C., de Puig, H., Bosch, I., Gehrke, L., & Hamad‐Schifferli, K. (2017) · Molecular Systems Design & Engineering · doi:10.1039/c7me00052a · Cited by 38
Ben‐Shachar, R., & Koelle, K. (2018) · Nature Communications · doi:10.1038/s41467-018-04595-w · Cited by 38
Nanosuspension of quercetin: preparation, characterization and effects against Aedes aegypti larvae
Pessoa, L. Z. D. S., Duarte, J. L., Ferreira, R. M. D. A., Oliveira, A. E. M. D. F. M., Cruz, R. A. S., Faustino, S. M. M., Carvalho, J. C. T., Fernandes, C. P., Souto, R. N. P., & Araújo, R. S. (2018) · Revista Brasileira de Farmacognosia · doi:10.1016/j.bjp.2018.07.003 · Cited by 40
Lai, S.-C., Huang, Y.-Y., Shu, P., Chang, S., Hsieh, P., Wey, J., Tsai, M.-H., Ben, R.-J., Hsu, Y.-M., Fang, Y., et al. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.00221-19 · Cited by 38
“RNA detection, IgM/IgG antibody detection, and NS1 antigen detection (16-21).”
BackgroundTree, M. O., Londono-Renteria, B. L., Troupin, A., Clark, K. M., Colpitts, T. M., & Conway, M. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-42803-9 · Cited by 40
Kühl, N., Graf, D., Bock, J., Behnam, M. A. M., Leuthold, M. M., & Klein, C. D. P. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00413 · Cited by 40
Wolbachia Inhibits Binding of Dengue and Zika Viruses to Mosquito Cells
Lü, P., Sun, Q., Fu, P., Li, K., Liang, X., & Xi, Z. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01750 · Cited by 38
Aryati, A., Wrahatnala, B. J., Yohan, B., Fanny, M., Hakim, F. K. N., Sunari, E. P., Zuroidah, N., Wardhani, P., Santoso, M. S., Husada, D., et al. (2020) · Viruses · doi:10.3390/v12090913 · Cited by 38
“7 kb single-stranded positive-sense RNA genome encodes three structural (C, prM/M, E) and seven non-structural (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5) proteins [2,3].”
Outbreak of severe dengue associated with DENV-3 in the city of Manado, North Sulawesi, Indonesia
Tatura, S. N. N., Denis, D., Santoso, M. S., Hayati, R., Kepel, B. J., Yohan, B., & Sasmono, R. T. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.03.065 · Cited by 38
Cabrera-Romo, S., Recio-Tótoro, B., Alcalá, A. C., Lanz, H., del Ángel, R. M., Sánchez-Cordero, V. M., Rodríguez‐Moreno, Á., & Ludert, J. E. (2014) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0361 · Cited by 38
“The disease is endemic in more than 100 countries where an estimated 100 million cases are reported annually, associated with more than 25,000 fatalities, mainly in children < 5 years of age.(6) Mexico is a country endemic for dengue, where all 4 DENV serotypes are known to circulate.”
BackgroundLiu, H., Zhang, L., Sun, J., Chen, W., Li, S., Wang, Q., Yu, H., Xia, Z., Jin, X., & Wang, C. (2017) · Journal of Virology · doi:10.1128/jvi.02234-16 · Cited by 40
“Dengue virus infection is one of the most significant emerging diseases that challenges the global public health system (4, 25) and one for which there are no effective preventative or therapeutic measures.”
BackgroundMatysiak, A., & Roess, A. (2017) · Journal of Tropical Medicine · doi:10.1155/2017/8947067 · Cited by 43
“In 2001, the Americas alone reported over 652,212 cases of dengue of which 15,500 were DHF, nearly double the cases reported for the same region in 1995 [12].”
BackgroundGuerrero, N. A. S., Muñoz, A. L., Losada-Barragán, M., Torres, O., Rodríguez, A. K., Rangel, H. R., & Bello, F. J. (2021) · Pathogens and Disease · doi:10.1093/femspd/ftab043 · Cited by 39
Hao, J., Li, J., Zhang, Z., Yang, Y., Zhou, Q. S., Wu, T., Chen, T., Wu, Z., Zhang, P., Cui, J., et al. (2022) · Autophagy · doi:10.1080/15548627.2022.2126614 · Cited by 39
Kim, S., Yang, I., Kim, J., Lee, K., & Jang, Y. (2015) · European Journal of Immunology · doi:10.1002/eji.201444988 · Cited by 38
Massangaie, M., Pinto, G., Padama, F., Chambe, G., da Silva, M., Mate, I., Chirindza, C., Ali, S., Agostinho, S., Chilaule, D., et al. (2015) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.15-0543 · Cited by 37
Evolutionary potential of the extrinsic incubation period of dengue virus inAedes aegypti
Ye, Y. H., Chenoweth, S. F., Carrasco, A. M., Allen, S. L., Frentiu, F. D., van den Hurk, A. F., Beebe, N. W., & McGraw, E. A. (2016) · Evolution · doi:10.1111/evo.13039 · Cited by 37
Yong, Y. K., Tan, H. Y., Soe, H. J., Shankar, E. M., Natkunam, S. K., Sathar, J., Manikam, R., & Sekaran, S. D. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1226-4 · Cited by 43
“Background Dengue virus (DENV) infection remains the most common arthropod-borne viral infection worldwide [1, 2], with a recent global estimate suggesting that ~390 million clinical DENV cases occur annually [3].”
Development of Peptide Vaccines in Dengue
Reginald, K., Chan, Y., Plebanski, M., & Poh, C. L. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612823666170913163904 · Cited by 43
“It causes an annual estimated 390 million infections, of which 500,000 require hospitalization and 25,000 deaths are reported [2, 3].”
BackgroundRecognizing spatial and temporal clustering patterns of dengue outbreaks in Taiwan
Lai, W.-T., Chen, C.-H., Hung, H. Y., Chen, R., Shete, S. S., & Wu, C. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3159-9 · Cited by 37
“the disease burden and changing behaviors to improve vector control [4].”
BackgroundIndonesia Dengue Fever: Status, Vulnerability, and Challenges
Haryanto, B. (2018) · IntechOpen eBooks · doi:10.5772/intechopen.82290 · Cited by 37
“About 50 million dengue infections occur every year [2, 3], and approximately 500,000 patients are hospitalized of whom dominated by children [2–7].”
BackgroundDengue Virus Degrades USP33–ATF3 Axis via Extracellular Vesicles to Activate Human Microglial Cells
Mishra, R., Lahon, A., & Banerjea, A. C. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000411 · Cited by 43
“Dengue fever is caused by dengue virus (DENV), a member of family Flaviviridae, and has been recently recognized as the second leading cause of acute febrile disease in travelers (1, 2).”
BackgroundVector biology prospects in dengue research
Lambrechts, L., & Failloux, A. (2012) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762012000800022 · Cited by 38
“With at least two-fifths of the world’s population living in areas that are vulnerable to dengue epidemics and 50-100 million infections each year, dengue is the most prevalent arboviral disease of humans worldwide (Guzman et al. 2010).”
BackgroundDengue Virus Directly Stimulates Polyclonal B Cell Activation
Correa, A. V., Berbel, A. C. E. R., Papa, M. P., de Morais, A. T. S., Peçanha, L. M., & de Arruda, L. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143391 · Cited by 37
“According to the World Health Organization dengue incidence has highly increased over the past 50 years, turning this infection the most important arthropod-born disease in the world and a global health challenge [1, 2].”
BackgroundProduction of a Recombinant Dengue Virus 2 NS5 Protein and Potential Use as a Vaccine Antigen
Alves, R. P. D. S., Pereira, L. R., Maeda, D. L. N. F., Salvador, F. S., Andreata‐Santos, R., Zanotto, P. M. D. A., Romano, C. M., Amorim, J. H., & Ferreira, L. C. D. S. (2016) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00081-16 · Cited by 37
“A recent study showed that, annually, an average of 96 million DENV-infected people develop symptoms with severity sufficient to change their routines (1); according to previous studies, about 500,000 cases develop into severe forms of disease, which may include hemorrhage and shock syndrome (9).”
BackgroundTripp, R. A., & Ross, T. M. (2016) · Expert Review of Vaccines · doi:10.1080/14760584.2016.1192474 · Cited by 37
Neglected Tropical Diseases in the Post-Genomic Era
Buscaglia, C. A., Kissinger, J. C., & Agüero, F. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.06.002 · Cited by 40
“Dengue Dengue virus Flavivirus Genomes for all dengue virus serotypes (DENV-1–4) are available (reviewed in [149]), and functional RNA elements of the genome have been described [150].”
BackgroundHuang, C., Kuo, L.-L., Yang, K. D., Lin, P.-S., Lu, P., Lin, C.-C., Chang, K., Chen, T.-C., Lin, W., Lin, C., et al. (2012) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2012.07.011 · Cited by 36
“Because the soluble form of NS1 can be detected in the bloodstream, tests such as antigen-capture enzyme-linked immunosorbent assay (ELISA), lateral flow antigen detection, and measurement of NS1-specific immunoglobulin (Ig)M and IgG responses have been developed.(5) Dengue is a notifiable infectious disease in Taiwan…”
BackgroundFrequency of dengue virus infection in blood donors in Sistan and Baluchestan province in Iran
Aghaie, A., Aaskov, J., Chinikar, S., Niedrig, M., Banazadeh, S., & Mohammadpour, H. K. (2013) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2013.07.034 · Cited by 36
“Travelers from endemic areas might serve as the vehicles for further spread [9]; thus, the rate of introduction of new viruses in a population is increased.”
BackgroundKim, S., Jung, D., Yang, I.-Y., Jang, S., Kim, J., Truong, T. T., Pham, T. V., Truong, N. U., Lee, K., & Jang, Y. (2013) · International Immunology · doi:10.1093/intimm/dxt029 · Cited by 38
Gupta, E., Mohan, S., Bajpai, M., Choudhary, A., & Singh, G. (2012) · Journal of Vector Borne Diseases · doi:10.4103/0972-9062.213384 · Cited by 36
Manakkadan, A., Joseph, I., Prasanna, R. R., kunju, R. I., Kailas, L., & Sreekumar, E. (2013) · Virology Journal · doi:10.1186/1743-422x-10-37 · Cited by 36
“Infection with one serotype confers life-long protective immunity against a future infection with the same serotype, but not against the other three [2,3].”
Backgroundvan den Berg, H., Velayudhan, R., Ebol, A. P., Catbagan, B. H., Turingan, R., Tuso, M., & Hii, J. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-269 · Cited by 41
“Conversely, dengue has increased in importance in Southeast Asia but has so far failed to attract major international funding [30-32].”
BackgroundBalasubramanian, A., Manzano, M., TERAMOTO, T., Pilankatta, R., & Padmanabhan, R. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.08.014 · Cited by 39
“Dengue virus (DENV) belongs to the flavivirus genus of the Flaviviridae family and is endemic throughout tropical and sub-tropical countries in the world (for reviews, see (Beasley, 2005; Gould and Solomon, 2008; Guzman et al., 2010; Lindenbach and Rice, 2003) causing frequent epidemics.”
BackgroundMolecular Responses of Human Retinal Cells to Infection with Dengue Virus
Carr, J. M., Ashander, L. M., Calvert, J. K., Ma, Y., Aloia, A. L., Bracho, G. G., Chee, S.-P., Appukuttan, B., & Smith, J. R. (2017) · Mediators of Inflammation · doi:10.1155/2017/3164375 · Cited by 36
“Human infection with dengue virus (DENV) is transmitted by Aedes species mosquitos and presents a broad spectrum of disease, ranging from subclinical to “severe” dengue, which is characterized by life-threatening plasma leakage, hemorrhage, and/or organ failure [1, 2].”
BackgroundSpatiotemporal responses of dengue fever transmission to the road network in an urban area
Li, Q., Cao, W., Ren, H., Ji, Z., & Jiang, H. (2018) · Acta Tropica · doi:10.1016/j.actatropica.2018.03.026 · Cited by 36
Efficacy of geraniin on dengue virus type-2 infected BALB/c mice
Ahmad, S. A. A., Palanisamy, U. D., Khoo, J. J., Dhanoa, A., & Hassan, S. S. (2019) · Virology Journal · doi:10.1186/s12985-019-1127-7 · Cited by 36
“DENV genome is made up of a single stranded positive-sense RNA which encodes three structural (capsid [C], membrane [M], and envelope [E]) and seven non-structural (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) proteins [2].”
BackgroundTen-minute direct detection of Zika virus in serum samples by RT-LAMP
Estrela, P. F. N., Mendes, G. D. M., de Oliveira, K. G., Bailão, A. M., Soares, C. M. D. A., Assunção, N. A., & Duarte, G. R. M. (2019) · Journal of Virological Methods · doi:10.1016/j.jviromet.2019.113675 · Cited by 36
Xi, Y., Xu, C., Xie, Z., Zhu, D., & Dong, J.-M. (2019) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2019.06.003 · Cited by 36
Barban, V., Muñoz‐Jordán, J. L., Santiago, G. A., Mantel, N., Girerd-Chambaz, Y., Gulia, S., Claude, J., & Lang, J. (2012) · Virology · doi:10.1016/j.virol.2012.03.007 · Cited by 36
“It is responsible for 230 million infections annually worldwide with a continual increase of incidence in recent decades (Guzman et al., 2010; Beatty et al., 2011).”
BackgroundSynthetic 1,4-Pyran Naphthoquinones Are Potent Inhibitors of Dengue Virus Replication
da Costa, E. C. B., Amorim, R., da Silva, F. D. C., da Rocha, D. R., Papa, M. P., de Arruda, L. B., Mohana‐Borges, R., Ferreira, V. F., Tanuri, A., da Costa, L. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082504 · Cited by 36
Shrinet, J., Srivastava, P., & Sunil, S. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.01.162 · Cited by 38
Nikookar, S. H., Moosazadeh, M., Fazeli‐Dinan, M., Zaim, M., Sedaghat, M. M., & Enayati, A. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1129056 · Cited by 43
Autophagy Facilitates Antibody-Enhanced Dengue Virus Infection in Human Pre-Basophil/Mast Cells
Fang, Y.-T., Wan, S.-W., Lu, Y., Yao, J.-H., Lin, C., Hsu, L., Brown, M. G., Marshall, J. S., Anderson, R., & Lin, Y.-S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110655 · Cited by 39
“Dengue disease is a severe health problem in tropical or subtropical areas of the world [1,2].”
BackgroundGan, V. C. H., Lye, D. C., Thein, T.-L., Dimatatac, F., Tan, A. S., & Leo, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060946 · Cited by 35
“5 billion people primarily in the tropics and subtropics and is of increasing public health importance [1].”
BackgroundTargeted genome editing in Aedes aegypti using TALENs
Aryan, A., Myles, K. M., & Adelman, Z. N. (2014) · Methods · doi:10.1016/j.ymeth.2014.02.008 · Cited by 38
“In total, more than 2.5 billion people, mostly in tropical and subtropical regions, are potentially at risk for dengue (Guzman et al., 2010).”
BackgroundInfluentialHiguera-Mendieta, D. R., Cortés-Corrales, S., Quintero, J., & González-Uribe, C. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005016 · Cited by 43
Liang, C., Fang, J., Ooi, E. E., & Lee, Y. H. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00173 · Cited by 36
Mathematical modeling on T-cell mediated adaptive immunity in primary dengue infections
Sasmal, S. K., Dong, Y., & Takeuchi, Y. (2017) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2017.06.035 · Cited by 35
Zhu, G., Xiao, J., Zhang, B., Liu, T., Lin, H., Li, X., Song, T., Zhang, Y., Ma, W., & Hao, Y. (2017) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2017.11.314 · Cited by 40
TEMPO-based immuno-lateral flow quantitative detection of dengue NS1 protein
Sinawang, P. D., Fajs, L., Elouarzaki, K., Nugraha, J., & Marks, R. S. (2017) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2017.12.043 · Cited by 35
Milisavljevič, N., Konkoľová, E., Kozák, J., Hodek, J., Veselovská, L., Sýkorová, V., Čížek, K., Pohl, R., Eyer, L., Svoboda, P., et al. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00829 · Cited by 35
Barros, M. T., Veletić, M., Kanada, M., Pierobon, M., Vainio, S. J., Balasingham, I., & Balasubramaniam, S. (2021) · IEEE Transactions on Molecular Biological and Multi-Scale Communications · doi:10.1109/tmbmc.2021.3071780 · Cited by 41
“DENV Initiates by glycoprotein E protein binding to DC-SIGN, a C-type lectin IFN-α, IL-6, IL-15, TNF-α, IL-1RA, CXCL8, CCL3, CCL4, CCL5, CCL11, M-CSF, G-CSF, ICAM-1, LSelectin, P-Selectin, CD40, CD40L, Fas, FasL, TRAILR2, TRAIL-R3, RANK-L, C3a, IL-2R, TNF-R1 Envelope glycoprotein (non-neutralising antibodies may cause…”
Ojha, R. P., Singh, P., Azad, U. P., & Prakash, R. (2022) · Electrochimica Acta · doi:10.1016/j.electacta.2022.140069 · Cited by 35
Rao, M. R. K., Padhy, R. N., & Das, M. K. (2015) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2015.10.019 · Cited by 35
“In recent years, both dengue and malaria fever have become leading causes of morbidity and mortality in tropical and subtropical areas throughout the world [1], and approximately two-fifths of the world population lives in areas that are at risk for dengue [2—4].”
BackgroundAedes aegypti as a Vector of Flavivirus
Muktar, Y., Tamerat, N., & Shewafera, A. (2016) · Journal of Tropical Diseases · doi:10.4172/2329-891x.1000223 · Cited by 50
“Humans are the primary host of the virus and an infection can be acquired even in a single bite [54,55].”
BackgroundKuo, F., Wen, T., & Sabel, C. E. (2018) · Annals of the American Association of Geographers · doi:10.1080/24694452.2017.1407630 · Cited by 40
“Guzman et al. (2010), however, commented that the EIP is about ten days and is much shorter at high ambient temperatures.”
BackgroundAtualização Clínica sobre Diagnóstico, Tratamento e Prevenção da Dengue
Seixas, J., Luz, K. G., & Pinto, V. L. (2024) · Acta Médica Portuguesa · doi:10.20344/amp.20569 · Cited by 34
Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity
Chiang, C.-Y., Hsieh, C.-H., Chen, M., Tsai, J.-P., Liu, H., Liu, S., Chong, P. C.-S., Leng, C., & Chen, H. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.01.041 · Cited by 34
“[1] Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, et al.”
BackgroundJaenisch, T., IDAMS, Sakuntabhai, A., DENFREE, Wilder‐Smith, A., & DengueTools (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002320 · Cited by 34
“Dengue is a major international public health concern and one of the most important arthropod-borne diseases [1].”
BackgroundLindow, J. C., Durbin, A. P., Whitehead, S. S., Pierce, K. K., Carmolli, M. P., & Kirkpatrick, B. D. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.05.075 · Cited by 34
Thanachartwet, V., Desakorn, V., Sahassananda, D., Jittmittraphap, A., Oer-Areemitr, N., Osothsomboon, S., Surabotsophon, M., & Wattanathum, A. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004961 · Cited by 34
“The incidence has dramatically increased during the last 50 years (by 30-fold) for all four dengue virus serotypes (DENV 1–4) in more than 100 countries, including those in Southeast Asia, Central and South America, the Western Pacific, Africa, and the Eastern Mediterranean [2,3].”
BackgroundA novel predictor of severe dengue: The aspartate aminotransferase/platelet count ratio index (APRI)
Zhang, H., Xie, Z., Xushuo, X., Ou, Y.-Y., Zeng, W., & Zhou, Y. (2018) · Journal of Medical Virology · doi:10.1002/jmv.25021 · Cited by 34
Enfermedades infecciosas relacionadas con el agua en el Perú
Cabezas, C. (2018) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2018.352.3761 · Cited by 34
Chen, W.-C., Simanjuntak, Y., Chu, L.-W., Ping, Y., Lee, Y.-L., Lin, Y., & Li, W. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01779 · Cited by 34
Poltep, K., Phadungsombat, J., Nakayama, E. E., Kosoltanapiwat, N., Hanboonkunupakarn, B., Wiriyarat, W., Shioda, T., & Leaungwutiwong, P. (2021) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed6030162 · Cited by 39
Tricou, V., Eyre, S., Ramjee, M., Collini, P., Mojares, Z. R., Loeliger, E., Mandarić, S., Rauscher, M., Brose, M., Lefevre, I., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.01.007 · Cited by 34
Lin, D. C.-D., Weng, S., Tsao, P., Chu, J. J. H., & Shiao, S.-H. (2023) · Parasites & Vectors · doi:10.1186/s13071-023-05778-1 · Cited by 34
“Whether differential interactions arise between the DENV serotypes in co-infection scenarios is also worth pursuing, as all four DENV serotypes (DENV1–4) are spreading throughout Asia, Africa, and the Americas [53].”
BackgroundUsme-Ciro, J. A., Lopera-Madrid, J., Enjuanes, L., Almazán, F., & Gallego-Gómez, J. C. (2013) · Virus Research · doi:10.1016/j.virusres.2013.12.001 · Cited by 38
“Dengue has become the main arthropod-borne viral disease n several tropical and subtropical countries, causing more than 0–100 million cases and 500,000 hospitalizations annually around he world (Guzman et al., 2010).”
Chiang, C.-Y., Huang, M., Hsieh, C.-H., Chen, M., Liu, H., Tsai, J.-P., Li, Y.-S., Chang, C.-Y., Liu, S., Chong, P. C.-S., et al. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001645 · Cited by 34
“People living in the tropical and subtropical areas are at risk of dengue virus infection, and more than 50 million dengue infected cases occur worldwide each year [1,2].”
BackgroundRabaa, M. A., Klungthong, C., Yoon, I., Holmes, E. C., Chinnawirotpisan, P., Thaisomboonsuk, B., Srikiatkhachorn, A., Rothman, A. L., Tannitisupawong, D., Aldstadt, J., et al. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001990 · Cited by 34
“Recent estimates are that over 50 million DENV infections occur each year, including 500,000 hospitalizations for DHF, primarily among children [1,2].”
Scaling of Stochasticity in Dengue Hemorrhagic Fever Epidemics
Aguiar, M., Kooi, B. W., Martins, J., & Stollenwerk, N. (2012) · Mathematical Modelling of Natural Phenomena · doi:10.1051/mmnp/20127301 · Cited by 34
“Infection by an antibody-virus complex suppresses innate immune responses, increasing intracellular infection and generating inflammatory citokines and chemokines that, collectively, result in enhanced disease [8, 12, 24–26, 28, 30].”
BackgroundRockstroh, A., Barzon, L., Pacenti, M., Palù, G., Niedrig, M., & Ulbert, S. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004218 · Cited by 34
“half a million hospitalizations and several thousands of fatalities are caused by DENV every year [3,4].”
Backgroundten Bosch, Q. A., Singh, B. K., Hassan, M. R. A., Chadee, D. D., & Michael, E. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004680 · Cited by 34
Kalimuthu, K., Panneerselvam, C., Chou, C., Lin, S., Tseng, L., Tsai, K., Murugan, K., & Hwang, J. (2016) · Hydrobiologia · doi:10.1007/s10750-016-2943-z · Cited by 34
“It is endemic to tropical and subtropical countries, especially in urban and suburban areas (Guzman et al., 2010).”
BackgroundAssessment of optimal strategies in a two-patch dengue transmission model with seasonality
Kim, J. E., Lee, H., Lee, C. H., & Lee, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173673 · Cited by 34
Hyrina, A., Meng, F., McArthur, S. J., Eivemark, S., Nabi, I. R., & Jean, F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174483 · Cited by 36
Household costs of hospitalized dengue illness in semi-rural Thailand
Tozan, Y., Ratanawong, P., Sewe, M. O., Wilder‐Smith, A., & Kittayapong, P. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005961 · Cited by 35
Li, P., Jin, Y., Qi, F., Wu, F., Luo, S., Cheng, Y., Montgomery, R. R., & Qian, F. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00113 · Cited by 38
“Keywords: SIRT6, dengue virus, proinflammatory cytokines, NF-κB p65, RLR, TLR3 INTRODUCTION Dengue virus (DENV) is a mosquito-transmitted single-stranded RNA virus, causing an acute systemic viral disease and is a significant public health concern (Guzman et al., 2010).”
BackgroundSharma, K. K., Lim, X.-X., Tantirimudalige, S. N., Gupta, A., Marzinek, J. K., Holdbrook, D. A., Lim, X. Y., Bond, P. J., Anand, G. S., & Wohland, T. (2019) · Structure · doi:10.1016/j.str.2018.12.006 · Cited by 33
Dengue: A Growing Menace -- A Snapshot of Recent Facts, Figures & Remedies
Bhattacharya, M. K., Maitra, S., Ganguly, A., Bhattacharya, A., & Sinha, A. (2013) · International Journal of Biomedical Science · doi:10.59566/ijbs.2013.9061 · Cited by 34
“Further investigations by John Burton Cleland and Joseph Franklin Siler completed the basic understanding of dengue transmission (2, 3).”
BackgroundInfluentialOng, S. Q., Isawasan, P., Ngesom, A. M. M., Shahar, H., Lasim, A. M., & Gomesh, N. (2023) · Scientific Reports · doi:10.1038/s41598-023-46342-2 · Cited by 33
Plant defences against ants provide a pathway to social parasitism in butterflies
Patricelli, D., Barbero, F., Occhipinti, A., Bertea, C. M., Bonelli, S., Casacci, L. P., Zebelo, S. A., Crocoll, C., Gershenzon, J., Maffei, M. E., et al. (2015) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2015.1111 · Cited by 33
Dengue Virus Serotype-2 Interferes with the Formation of Neutrophil Extracellular Traps
Moreno‐Altamirano, M. M. B., Rodríguez‐Espinosa, O., Rojas-Espinosa, O., Pliego‐Rivero, B., & Sánchez‐García, F. J. (2015) · Intervirology · doi:10.1159/000440723 · Cited by 38
Widespread signatures of local mRNA folding structure selection in four Dengue virus serotypes
Goz, E., & Tuller, T. (2015) · BMC Genomics · doi:10.1186/1471-2164-16-s10-s4 · Cited by 35
Hu, D., Fry, S. R., Huang, J. X., Ding, X., Qiu, L., Pan, Y., Chen, Y., Jin, J., McElnea, C., Buechler, J., et al. (2013) · Biosensors · doi:10.3390/bios3030297 · Cited by 33
“5 billion people live in endemic areas, with 50 to 100 million people suffering from dengue infection, resulting in approximately 25,000 deaths reported annually [1].”
BackgroundĐăng, T. N., Naka, I., Sa-ngasang, A., Anantapreecha, S., Chanama, S., Wichukchinda, N., Sawanpanyalert, P., Patarapotikul, J., Tsuchiya, N., & Ohashi, J. (2014) · BMC Medical Genetics · doi:10.1186/1471-2350-15-58 · Cited by 33
“The clinical outcome of DSS is affected by a number of factors [2,3].”
BackgroundLaboratory Diagnosis of Dengue Infection: Current Techniques and Future Strategies
Subedi, D., & Taylor-Robinson, A. W. (2014) · Open Journal of Clinical Diagnostics · doi:10.4236/ojcd.2014.41012 · Cited by 33
“Due to a combination of population growth, unplanned urbanisation, global warming, lack of efficient mosquito control, increased air travel and insufficient public healthcare facilities, a 30-fold increase in dengue has been reported worldwide between 1960 and 2010 [1]-[3].”
BackgroundChao, D., Galula, J. U., Shen, W.-F., Davis, B. S., & Chang, G. J. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02735-14 · Cited by 33
A portable approach for the surveillance of dengue virus-infected mosquitoes
Muller, D. A., Frentiu, F. D., Rojas, A., Moreira, L. A., O’Neill, S. L., & Young, P. R. (2012) · Journal of Virological Methods · doi:10.1016/j.jviromet.2012.03.033 · Cited by 33
Identification of covalent active site inhibitors of dengue virus protease
Koh, X., Joy, J. K., Wang, S. F., Kwek, P. Z., Wee, J., Wan, K. F., Gayen, S., Chen, A., Kang, C., Lee, M. A., et al. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s94207 · Cited by 34
Ali, A., Ahmad, H., Idrees, M., Zahir, F., & Ali, I. (2016) · Virology Journal · doi:10.1186/s12985-016-0603-6 · Cited by 33
“tions during his/her life span [4, 5].”
Q63, a novel DENV2 RdRp non-nucleoside inhibitor, inhibited DENV2 replication and infection
Yao, X., Guo, S., Wu, W., Wang, J., Wu, S., He, S., Wan, Y., Nandakumar, K. S., Chen, X., Sun, N., et al. (2018) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2018.06.012 · Cited by 33
Metadata
- Authors
- Guzman, M. G., Halstead, S. B., Artsob, H., Buchy, P., Farrar, J., Gubler, D. J., Hunsperger, E., Kroeger, A., Margolis, H. S., Martínez, E., Nathan, M. B., Pelegrino, J. L., Simmons, C., Yoksan, S., & Peeling, R. W.
- Affiliations
- Public Health Agency of Canada (CA)
- Institut Pasteur du Cambodge (KH)
- Oxford University Clinical Research Unit (VN)
- National University of Singapore (SG)
- Centers for Disease Control and Prevention (US)
- World Bank (US)
- Instituto de Medicina Tropical “Pedro Kourí” (CU)
- World Health Organization (CH)
- Mahidol University (TH)
- Corresponding author
- Peeling, Rosanna W.
- ORCID
- Venue
- Nature Reviews Microbiology
- Published
- 2010-12
- Volume
- 8
- Issue
- S12
- Pages
- S7-S16
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- PMC
- PMC4333201
- OpenAlex
- W2042479028
- Cited by
- 2,082
- References
- 130
- Citations by year
- 2026: 68 · 2025: 104 · 2024: 94 · 2023: 135 · 2022: 116 · 2021: 133 · 2020: 140 · 2019: 127 · 2018: 142 · 2017: 151 · 2016: 163 · 2015: 189 · 2014: 186 · 2013: 161 · 2012: 132
- FWCI
- 15.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Funders
- Wellcome Trust (084368)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Mosquito-borne diseases and control
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Dengue and Mosquito Control Research
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Vectors
- Keywords
- dengue, dengue hemorrhagic fever, arboviruses, dengue serotypes, vector-borne diseases, dengue surveillance, outbreak response, integrated vector management, early diagnosis, dengue vaccine, antiviral agents, dengue control
- MeSH terms
- Americas, Asia, Southeastern, Dengue, Dengue Virus, Hospitalization, Humans, Insect Control, Pacific Islands
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.